LONG-TERM TRANSPLANTATION OUTCOMES IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE I: RESULTS FROM THE OXALEUROPE DATABASE
Elisabeth L. Metry(Emma Kinderziekenhuis), Jaap W. Groothoff(University of Amsterdam), Justine Bacchetta(Université Claude Bernard Lyon 1), Georges Deschênes(Hôpital Robert-Debré), Graham Lipkin(Queen Elizabeth Hospital Birmingham), Larisa Prikhodina(Pirogov Russian National Research Medical University), Laure Collard(Centre Hospitalier Chrétien), Cécile Acquaviva(Hospices Civils de Lyon), Nilufar Mohebbi(University Hospital of Zurich), Shabbir Moochhalla(Royal Free London NHS Foundation Trust), Casper Franssen(University Medical Center Groningen), Hessel Peters‐Sengers(Amsterdam Neuroscience), Sally-ann Hulton(University of Birmingham), Bernd Höppe(University of Bonn), Bodo B. Beck(University of Cologne), Georgia Mandrile, Sander F. Garrelfs(Emma Kinderziekenhuis), Gill Rumsby(University College London Hospitals NHS Foundation Trust), Markus J. Kemper(University of Zurich), Michiel J.S. Oosterveld(Emma Kinderziekenhuis)
Data Archiving and Networked Services (DANS)
October 1, 2021
Cited by 0
Related Papers
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411
The primary hyperoxalurias
|Kidney International|2009|373